E

Eikon Therapeutics

249 employees

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical
Life Science

Date founded

2019

Funding rounds raised

Total raised

$518M

from 12 investors over 12 rounds

E

Eikon Therapeutics raised $518M on January 6, 2022

Investors: StepStone Group, T. Rowe Price, Lux Capital, Horizons Ventures, Schroders Capital, The Column Group and Innovation Endeavors

E

Eikon Therapeutics raised $148M on May 5, 2021

Investors: Lux Capital, The Column Group, Innovation Endeavors and Foresite Capital

E

Eikon Therapeutics raised undisclosed on January 1, 2019

Investors: Lux Capital

FAQ